Vol. 66, No. 4,1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ABNORMAL GANGLIOSIDE FIBROBLASTS
Gideon
ACCUMULATION IN CULTURED
FROM PATIENTS
Bach,
Maimon
WITH MUCOLIPIDOSIS
M. Cohen and Gertrude
IV
Kohn
Department of Human Genetics Hadassah-Hebrew University Medical Center P.O.B. 499, Jerusalem, Israel. Received
August
25,1975 SUMMARY
Extracts of cultured skin fibroblasts derived from patients with mucolipidosis IV showed a marked increase and altered distribution of GM3 and GD3 gangliosides. GD3 is elevated 1.5-2 times that of normal whereas GM3 is elevated No abnormalities were found in the neutral glycolipids. to a lesser extent. These two gangliosides apparently comprise most of the accumulated lipid-like material observed on ultrastructural analysis in this disease. Recently, cornea1
opacities,
abnormalities from
five
material
and,
glycoprotein
children
mental
revealed
to a lesser
extent,
of these
a mucolipidosis
(4).
accumulated
substances,
Abbreviations: N-acetyl Galactose
and motor
with
However,
assigned nor
the basic
granular
disorder,
(1,3).
Acid
derived
a lipid-like
indicative
of
storage
The simultaneous tissues fibroblasts
suggested (1)
and the name Mucolipidosis Neither defect
the nature
has as yet
GD3, NANA-cr(2->8)-NANA-u(2->3)-gal-8(1->4)-Glc-Ceramide GM3, NANA-a(2->3)-gal-8-(l->4)-Glc-Ceramide Neuraminic glc-Glucose
with
of these
in extraneurological
mucolipidoses
enzymatic
material
of cultured
no skeletal of biopsies
filled
origin
staining
analysis
to this
but
bodies
The lysosomal
enzymatic
congenital
microscopy
storage
of substances
described
retardation
amorphic
by histochemical
two types
bilateral
Electron
numerous
mucopolysaccharide.
any of the already was tentatively
manifesting
(1,2,3).
of tissues
was established
accumulation
NANA gal
progressive
and/or
organelles
excluded
old
have been described
a variety
(ML IV)
two year
been
of the identified.
IV
Vol. 66, No. 4, 1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMvtUNlCATlONS
Since all the ML IV patients are still limited
to cultured skin fibroblasts,
alive,
studies, by necessity,
and this paper identifies
were
GM3and GD3
gangliosides as the major accumulated substances in these cells. MATERIALSANDMETHODS. Cell Culture.-
Skin fibroblasts
obtained from three ML IV patients
normal controls were propagated in 100 mmplastic in an atmosphere of 95%air,
tissue culture
5% C02, using Ham's F-10 nutrient
and three
flasks
(Falcon),
mediumsupplemented
with 10% Fetal Calf Serum (GIBCOCo., Grand Island, N.Y. ).
Cultures with a
density of 5 x lo6 cells were used for biochemical studies. -Radioisotopes.-
[3H]-6-glucosamine (13.4 ci/mmol),
[3H]-l-galactose
were obtained from Amersham,Buckinghamshire, England. in these studies were of analytical
(13 Ci/mmol),
All other reagents used
grade.
Cultures were incubated with the appropriate
Radioactive labeling.-
48 hours prior to harvest.
isotope for
The labeling by [3H]-glucosamine or [3H]-galactose
was achieved in an F-10 glucose-free medium, to which 0.2 mg glucose/mlwas added with the radioactive Lipid extraction.-
precursor.
Cells were washed twice with 0.9% sodium chloride
protein determined by the Lowry technique (5).
Aliquots
containing
protein were homogenized in 19 volumes of chloroform-methanol 2:l Following centrifugation extracted
with chloroform-methanol 1:2 (v/v).
and partitioned
phase was extracted water (6). distilled
chloroform-methanol ratio
for two minutes.
supernatants were of 2:l with pure
The upper phase was collected
The dialysate (2:l)
was lyophilized,
while the lower
exhaustively
against
dissolved in 0.3 ml of
and then sonicated for two minutes in an ultrasonic
The lower phase of the extraction
under nitrogen,
(v/v>.
three more times with pure upper phase solvents containing
chloroform-methanol bath.
(6).
The resulting
The upper phases were combined and dialyzed water.
1 mg of
(10,000 g for 30 min), the insoluble residue was re-
combined,and adjusted to a final chloroform,
and total
mixture was evaporated to dryness
redissolved in 0.3 ml chloroform-methanol
(2:l)
and sonicated
Vol. 66, No. 4,1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Table 1. Accumulation of [3li]-glucosamine labeled compounds in fractionated fibroblasts, following chloroformmethanol extraction.
Fraction
ML IV fibroblasts cpm*
Normal fibroblasts cpm*
Total homogenate (freeze-thawed 3 x>
41000
33000
Upper phase
13000
5100
Lower phase
12000
12500
Insoluble residue **
14000
13000
* cpm represent total radioactivity in each fraction extracted from cells containing 1 mg protein. Conditions of labeling as described in Methods. **
The chloroform-methanol insoluble residue was suspended in 0.9% sodium chloride by vigorous shaking before counting.
Thin layer chromatography (TLC).precoated plates (Analtech).
This procedure was carried out on silica
The lower phase of the extraction
chromatographed in a 60:35:8 chloroform-methanol-water
solution was
mixture (v/v/v)
upper phase of the solution was developed in chloroform-methanol-2.5N (60:40:9).
Total lipids
were investigated
(7).
while the ammonia
by spraying the chromatography plates
with anthrone reagent which is sufficiently of lipid
Gel-G
sensitive
to detect at least lug
Gangliosides alone were detected by resorcinol
spray of TLC
plates (8). RESULTS. Fibroblasts
derived from ML IV patients
accumulation of [3H]-glucosamine-labeled
extraction
of [3H]-glucosamine-labeled solution
chloroform-methanol.
marked
compoundsin the upper phase following
incubation of the cells with the isotope. distribution
showeda consistently
Table 1 shows a representative compoundsin the various phases of the
from three ML IV affected
fibroblast
lines extracted
Similar results were obtained using [3H]-galactose
precursor. 1485
with as
BIOCHEMICAL
Vol. 66, No. 4, 1975
Table
Cell
Lipid-bound
2.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
sialic acid in ML IV affected control fibroblasts.
Line
pg sialic acid/ mg protein
ML IV
4.95
ML IV
3.25
average
4.10
Control
2.04
Control
1.79
average
Since consists
1.91
the upper
mainly
determined.
phase
normal acid
More
via
that
than
twice
skin
N-acetyl Thin
layer
sides
in both
lipid
or quantitative
the detection in the lower theoretical Further
acid
was observed
that
phase,
it phase
evidence
2).
gangliosides
contain
N-acetyl
hexosamine
be labeled
a significant studied
abnormal
increase
of both
experiment phase
be
(GM3 and GD3) in (lo),
the
sialic
(7)
extracted
is
ganglioside
most
extremely
Although
of this distribution
no qualitative It
extracts.
should
sensitive GM3 is
to assume that the repeated
eliminated
from
GD3 and GM3 ganglio-
revealed
and ML IV cell
technique
1486
in two
(Fig.1).
solutions
by chromatography.
reasonable solvents
solutions,
control
spray
should
was
by [3H]-glucosamine
phase
in this
of the lower
It
fraction
medium.
of the upper
separated
for
(Table
two major
between
is
cells
of the
the anthrone
of lipids
upper
to control
nonetheless
content
differences out
sialic
in a low glucose
ML IV patients
The total
be pointed
as much lipid-bound
will
indicated
dialysis,
of this
chromatography
ML IV fibroblasts,
following acid
fibroblasts
mannosamine
mixture, sialic
neither
gangliosides
extraction
the lipid-bound
as compared
although
cultured of these
of this
of gangliosides,
of the ML IV cultures remembered
and normal
for
soluble
extraction
also by
ganglioside. in ML IV fibroblasts
BIOCHEMICAL
Vol. 66, No. 4, 1975
Figure
1.
Thin layer chromatography of upper phase (resorcinal spray): 1 - GM1 standard; 2 - GM3 standard; 3 and 4 - ML IV fibroblast extracts; 5 and 6 - control fibroblast extracts. Arrows indicate migration distance of GD3.
was obtained
by monitoring
labeledgangliosides located
and their
accumulation
vapor, radioactivity
control
whereas
fibroblast
layer
and strips,
one centimeter
quantitated.
This
of both
(Fig.2).
A 1.5-2
fold
values
was observed
in the
(approximately
lower
phase
extracts. 1487
[3H]-glucosamineThe gangliosides
wide, procedure
were also
GD3 and GM3 labeled
increase
in GM3 was much less
compounds
in
chromatography.
amounts
the increase
samine-labeled
thin
of radioactivity
of significant
Ml IV fibroblasts over
the pattern
following
by iodine
plate
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
removed
were from
the
demonstrated
the
gangliosides
in
of GD3 in ML IV fibroblasts 40% of the total
pronounced. was similar
radioactivity)
The distribution in both
of gluco.
ML IV and normal
Vol. 66, No. 4, 1975
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
a
GD~ 6MJ
2400 -
-
-
1800 1200 s .-+ x Lk
A
5
600O*-,,r c 2400-
e
1800-
E
, \, .
/" \, .H. 1 I I I 1 I 1 1 , 1 h.-. 2 4 6 8 10 12 14 centimeter from origin
0
2.
Thin layer a - Normal
DISCUSSION. European
Within
symptomotology. abnormal indicative
Electron bodies
lipidoses were
very
quantities
minute
numbers
allowed
limited
of cells.
when compared
experiments
performed
gangliosides significantly
normal
control
in MI IV cells, approximately
(the
it
using
that
these
control
organs
the levels in normal
compounds close (This
exhibit
skin
1488
clinical of
individuals, analysis
disorder
nor
the
as one of the
been called
Mucolipidosis
fibroblasts
from which
because
somewhat
more variability or brain.
of GDS, and to a lesser cultured
skin
in such The extent
pattern
GMS,
(10)
when compared
gangliosides,
GD3 contains
only small
fibroblasts)
Furthermore, a different
IV.
of the relatively
such as liver
to 20% of total is because
of Eastern
identical
enzymatic
of this
in ML IV fibroblasts.
GDS comprising 10% in
neither
expect
gangliosides:
the accumulation
has tentatively
gangliosides
elevated
the almost
can be extracted
to those
all
of the affected
classification
one might
indicate
major
cells,
tissues Since
of material Therefore,
children,
with
to the use of cultured
experiments
are
in several
or mucolipidoses,
Our studies
Israeli
has demonstrated
substances.
manifestations
known
five
have presented microscopy
of lipid-like
clinical
two years
origin,
cytoplasmic
,_._ 16 18
chromatography of [3H]-glucosamine labeled control; b - ML IV fibroblast extracts.
the past
(Ashkenazi)
b
4
'z;p
Figure
,
to
of distribution compared
two labeled
sialic
to acids).
BIOCHEMICAL
Vol. 66, No. 4,1975
On the lipid
other
hand,
bands
following
differences
This
bands
in ML IV cells
also
observed
were
noted
than
lamellar
ive
of water
soluble
the accumulated
definitive
information
and both possibility aspect
water
exists currently
both
that under
and brain
this
cells
more,
microscopy
lysosomal
defect
synthetic
pathway
clinical
whereas (13).
manifestations
structure
granular
storage
of these
bodies
was strongly
mucopolysaccharides.
suggest-
Attempts
have not as yet
to yielded
nature.
accumulate
in ML IV affected
the enzyme ganglioside
syndrome
bodies
two gangliosides.
fewer
macromolecules,
fibroblast
storage
amorphic
fibroblasts,
sialidase
may be due to a sialidase
(GM3 sphingolipodystrophy) of the affected
patients.
GM3 ganglioside
due to the deficiency electron
of these
Although
chemical
quantitative
(ll),
the
deficiency,
an
investigation.
GM3 and GD3 accumulate,
disorder
soluble
for
In a new gangliosidosis, in liver
and/or
nor
the lamellar
granular
12 different
ML IV and control
deposits,
their
as to their
as substrates
that
in ML IV cells.
GD3 and GM3 gangliosides serve
no qualitative
partially
lamellar
glycoproteins
identify
suggests
organelles,
at least
when comparing
at least
to the concentric
were
Since
strongly
revealed
However,
observed
consist
organelles
solutions
spray.
were
observation
In addition
phase
anthrone
in these
extracts. observed
TLC of lower
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Unlike
accumulates
of N-acetyl-galactosamine
has indicated
that
two disorders
and therefore
GM3 accumulates
ML IV, mainly
in which in the former
transferase.
ML IV can be categorized
GM3 s p hingolipodystrophy These
(12),
is also
can easily
due to an impaired
present
completely
Furtheras a biodifferent
been distinguished.
ACKNOWLEDGEMENTS. The technical assistance of Miss Marcia Zeigler and Mr. Robert Dworkin is deeply appreciated. This investigation was supported in part by Joint Research Fund of Hadassah Hospital and the Hebrew University. REFERENCES. 1. 2. 3.
Berman, E.R., Livni, N., Shapira, E., Merin, S., and Levij, I.S. (1974) J. Pediatrics 84, 519-526. Russell, A., Yatsiv, S., Livni, N., and Kohn, G. J. Pediatrics (submitted for publication). Merin, S., Livni, N., Berman, E.R., and Yatsiv, S. (1975) Invest. Ophthal. l4, 437-445.
1489
Vol. 66, No. 4, 1975
BIOCHEMICAL
AND BIOPHYSICAL
4.
RESEARCH COMMUNICATIONS
McKusick, V.A. (1972) Heritable disorders of connective tissue. 4th ed. pp. 641-665 Academic Press, NewYork. 5. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, J. (1951) J. Biol. Chem.193, 265-275. 6. Folch, J., Lees, M., and Sloane-Stanley, F. (1957) J. Biol. Chem. 226, 497-509. 7. Trevelyn, W.E., and Harrison, J.S. (1952) Biochem. J. so, 298-303. 81 Svennerholm, L. (1957) Biochem. Biophys. Acta 2, 604-611. 9. Warren, L. (1959) J. Biol. Chem.234, 1971-1975. 10. Dawson, G., Matalon, R., and Dorfman, A. (1972) J. Biol. Chem.247, 5944-5950. 11. Ohman, R., Rosenberg, A., and Svennerholm, L. (1970) Biochemistry 2, 3774-3782. 12. Max, S.R., Maclaren, N.K., Brady, R.O., Bradley, R.M., Rennels, M.B., Tanaka, J., Garcia, J.H., and Cornblath, M. (1974) New Eng. J. Med. 291, 929-931. 13. Fishman, P.H., Max, S.R., Tallman, J.F., Brady, R.O., Maclaren, N.K., and Cornblath, M. (1975) Science 187, 68-70.
1490